Apomorphine Hydrochloride and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Apomorphine Hydrochloride and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apomorphine
Brand name: Apokyn, APO-Go, APO-Go Pen, Uprima
Synonyms: Apomorphine
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apomorphine Hydrochloride-Insulin glargine, recombinant Subcutaneous
- Apomorphine Hydrochloride-Insulin glulisine
- Apomorphine Hydrochloride-Insulin Glulisine (Cartridges and Pens)
- Apomorphine Hydrochloride-Insulin Glulisine (Vials)
- Apomorphine Hydrochloride-Insulin glulisine Subcutaneous
- Apomorphine Hydrochloride-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Apomorphine Subcutaneous
- Insulin glargine and lixisenatide Subcutaneous-Apra
- Insulin glargine and lixisenatide Subcutaneous-Apraclonidine
- Insulin glargine and lixisenatide Subcutaneous-Apraclonidine Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Apraclonidine ophthalmic
- Insulin glargine and lixisenatide Subcutaneous-Apremilast